UC files opening brief to appeal CRISPR-Cas9 patent decision – Daily Californian
|
UC files opening brief to appeal CRISPR-Cas9 patent decision
Daily Californian Last week, the University of California filed an opening brief to appeal a decision by the U.S. Patent Trial and Appeal Board, or PTAB, which denied UC patent claims for CRISPR-Cas9 technology in eukaryotic cells. In February, PTAB determined that … |
